Insights

Strategic Partnerships Nivagen emphasizes a global alliance model with FDA qualified manufacturers to deliver cost savings and accelerated product launches, presenting opportunities to partner with CROs/CRAMs for co-development and with small manufacturers seeking US market entry.

US Market Opportunity With a large and aging pipeline of generic and off-patent products set to come off patent over the next decade, there is growing demand for affordable generics and behind-the-counter products, suggesting fertile ground for portfolio expansion and faster downstream sales through established channels.

Portfolio Evolution Recent asset divestiture to Hims & Hers indicates Nivagen is actively reshaping its unit mix; this creates opportunities to position complementary generic and OTC products, especially those leveraging LAI manufacturing or specialized generics, to fill gaps left by divested assets.

Tech-Driven Capabilities Investments in AI-enabled formulation, scalable manufacturing processes, and ERP/Cloud platforms signal efficiency in product development and supply chain; sales pitches can highlight faster time-to-market, lower compliance risk, and reliable manufacturing partnerships for new products.

Collaborative Growth A history of venture funding and strategic investments, plus active interest in partnerships with CROs, CRAMs, and global suppliers, opens doors for co-licensing opportunities, acquisitions, or joint ventures targeting US distributors and retail channels seeking cost-effective generics.

Similar companies to Nivagen Pharmaceuticals, Inc.

Nivagen Pharmaceuticals, Inc. Tech Stack

Nivagen Pharmaceuticals, Inc. uses 8 technology products and services including QuickBooks, WordPress, Anaplan, and more. Explore Nivagen Pharmaceuticals, Inc.'s tech stack below.

Media & News

Nivagen Pharmaceuticals, Inc.'s Email Address Formats

Nivagen Pharmaceuticals, Inc. uses at least 1 email format:
Nivagen Pharmaceuticals, Inc. Email FormatsExamplePercentage
FLast@nivagen.comJDoe@nivagen.com
100%

Frequently Asked Questions

What is Nivagen Pharmaceuticals, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Nivagen Pharmaceuticals, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Nivagen Pharmaceuticals, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s official website is nivagen.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Nivagen Pharmaceuticals, Inc. generate?

Minus sign iconPlus sign icon
As of August 2026, Nivagen Pharmaceuticals, Inc.'s annual revenue is estimated to be $50M - $100M.

What is Nivagen Pharmaceuticals, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s SIC code is 8732 - Commercial Economic, Sociological, and Educational Research and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Nivagen Pharmaceuticals, Inc. have currently?

Minus sign iconPlus sign icon
As of August 2026, Nivagen Pharmaceuticals, Inc. has approximately 157 employees across 2 continents, including North America and Asia. Key team members include Vice President - Projects And Manufacturing: V. M., General Manager - Quality: K. P. and Manager - Business Development: P. P. Explore Nivagen Pharmaceuticals, Inc.'s employee directory with LeadIQ.

What industry does Nivagen Pharmaceuticals, Inc. belong to?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc. operates in the Pharmaceutical Manufacturing industry.

What technology does Nivagen Pharmaceuticals, Inc. use?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s tech stack includes QuickBooks, WordPress, Anaplan, Hyperion, SAP, Barracuda Email Protection, Google Cloud and DocuSign.

What is Nivagen Pharmaceuticals, Inc.'s email format?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc.'s email format typically follows the pattern of FLast@nivagen.com. Find more Nivagen Pharmaceuticals, Inc. email formats with LeadIQ.

How much funding has Nivagen Pharmaceuticals, Inc. raised to date?

Minus sign iconPlus sign icon
As of August 2026, Nivagen Pharmaceuticals, Inc. has raised $31M in funding. The last funding round occurred on Aug 09, 2023 for $5M.

When was Nivagen Pharmaceuticals, Inc. founded?

Minus sign iconPlus sign icon
Nivagen Pharmaceuticals, Inc. was founded in 2009.
Nivagen Pharmaceuticals, Inc. logo

Nivagen Pharmaceuticals, Inc.

Pharmaceutical ManufacturingCalifornia, United States51-200 Employees

Nivagen Pharmaceuticals, Inc. is a pharmaceutical company engaged in the development, acquisition, and sale of generic prescription drugs and over-the-counter products for the North American market. It aims to deliver high-quality products at affordable prices by leveraging global partnerships with FDA-approved manufacturing facilities around the world, focusing on a model that combines development, licensing, and sales services. The firm emphasizes a strategic partnership approach to reduce costs for consumers while creating value across the supply chain, and it actively seeks collaborations with contract research and manufacturing organizations to co-develop products, as well as opportunities to acquire existing ones.
Headquartered in Sacramento, California, the company operates within the pharmaceutical manufacturing industry and positions itself as a specialty provider that can offer turnkey solutions to small FDA-qualified manufacturers seeking entry into the U.S. market. Nivagen’s activities include developing and co-developing products, acquiring licenses, and delivering sales and marketing services, with a stated focus on leveraging global alliances to expand its product portfolio. A recent development noted in industry coverage is the acquisition of Nivagen Pharmaceuticals, Inc. by PAI Pharma, supported by Olympus Partners, reflecting ongoing consolidation in the sector.

Section iconCompany Overview

Phone number
SIC Code
8732 - Commercial Economic, Sociological, and Educational Research
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2009
Employees
51-200

Section iconFunding & Financials

  • $31M

    Nivagen Pharmaceuticals, Inc. has raised a total of $31M of funding over 3 rounds. Their latest funding round was raised on Aug 09, 2023 in the amount of $5M as a Venture Round.

  • $50M - $100M

    Nivagen Pharmaceuticals, Inc.'s revenue is estimated to be in the range of $50M - $100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.